Страна: Ирландия
Язык: английский
Источник: HPRA (Health Products Regulatory Authority)
Fipronil
Merial Animal Health Limited
QP53AX15
Fipronil
10 percent weight/volume
Spot-on solution
POM: Prescription Only Medicine as defined in relevant national legislation
Dogs
fipronil
Ectoparasiticide
Authorised
1998-06-12
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Frontline Spot On Dog. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Spot-on solution. Clear to light brownish-yellow solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The treatment and prevention of infestations by fleas and ticks in dogs. Frontline Spot On Dog has been shown to significantly reduce the incidence of Flea Allergy Dermatitis. Ticks will usually detach from the treated host within 24 to 48 hours after infestation, without having had a blood meal. Frontline Spot On Dog rapidly controls infestations with_ Trichodectes canis_ (biting lice) on dogs. 4.3 CONTRAINDICATIONS In the absence of available data, the product should not be used on puppies less than 8 weeks old and/or weighing less than 2 kg. Do not use on sick (systemic diseases, fever….) or convalescent animals. Do not use in rabbits, as adverse reactions and even death could occur. This product is specifically developed for dogs. Do not use in cats, as this could lead to overdosing. Each pipette contains: Active Substance Fipronil 10 % w/v Excipients Butylhydroxyanisole (E320) 0.02 % w/v Butylhydroxytoluene (E321) 0.01 % w/v Non-aqueous vehicle q.s. to 100 % w/v I R I S H M E D I C I N E S B O A R D ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _0_ _/_ _0_ _2_ _/_ _2_ _0_ _1_ _4_ _C_ _R_ _N_ _ _ _7_ _0_ _1_ _7_ _2_ _1_ _0_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ Прочитать полный документ